Argan Inc. (NYSE: AGX) director trades 5,716 shares at $579.64

Rhea-AI Filing Summary

Argan Inc. director Jeffrey John Ronald Jr. reported selling 5,716 shares of common stock on July 31, 2026 at an average price of $579.64 per share in open-market transactions. After this sale, he holds 2,533 shares directly and 8,000 shares indirectly through a John R. Jeffrey IRA.

Insider Trade Summary

Net Seller: 5,716 shares

Net Sell 2 txns

Insider Jeffrey John Ronald Jr.

Role Director

Sold 5,716 shs ($3.31M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	5,716	$579.64	$3.31M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,533 shares (Direct); Common Stock — 8,000 shares (Indirect, John R. Jeffrey, IRA)

Footnotes (1)

1. F1. On July 31, 2026, the Reporting Person sold 5,716 shares of the Issuer's common stock on the open market at an average price of $579.64 per share.

Key Figures

Shares sold: 5,716 shares Average sale price: $579.64 per share Direct holdings after sale: 2,533 shares +1 more

4 metrics

Shares sold 5,716 shares Common stock sold by director Jeffrey John Ronald Jr. on July 31, 2026

Average sale price $579.64 per share Weighted average price for the 5,716 common shares sold in open-market transactions

Direct holdings after sale 2,533 shares Common stock held directly by Jeffrey John Ronald Jr. after the reported sale

Indirect IRA holdings 8,000 shares Common stock held indirectly through John R. Jeffrey, IRA as reported in the filing

Key Terms

open market, IRA, average price

3 terms

open market market

"sold 5,716 shares of the Issuer's common stock on the open market at an average price"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

IRA financial

"total_shares_following_transaction: 8000.0000, nature_of_ownership: John R. Jeffrey, IRA"

An individual retirement account (IRA) is a savings account designed to help people put aside money for their retirement, often with tax advantages that encourage long-term savings. It matters to investors because it can grow over time, providing financial security later in life, and offers benefits that can reduce current taxes or allow investments to compound more effectively.

average price financial

"on the open market at an average price of $579.64 per share"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 04:31 PM Accepted by SEC EDGAR 08/04/2026 - 04:30 PM Learn about SEC filing dates

FAQ

What insider stock sale did Argan (AGX) disclose for Jeffrey John Ronald Jr.?

Argan reported that director Jeffrey John Ronald Jr. sold 5,716 shares of common stock on July 31, 2026 at an average price of $579.64 per share in open-market transactions, according to his Form 4 insider filing with the SEC.

How many Argan (AGX) shares does Jeffrey John Ronald Jr. hold after the sale?

Following the reported transaction, Jeffrey John Ronald Jr. holds 2,533 Argan shares directly and 8,000 shares indirectly through a John R. Jeffrey IRA, as reflected in the Form 4 holdings information dated July 31, 2026.

At what price did the Argan (AGX) director sell his 5,716 shares?

The filing states that the 5,716 Argan common shares were sold at an average price of $579.64 per share. The footnote clarifies these were open-market sales executed on July 31, 2026, resulting in total proceeds based on that weighted average price.

Was the Argan (AGX) insider transaction executed on the open market?

Yes. A footnote explains that on July 31, 2026 the reporting person sold 5,716 shares on the open market at an average price of $579.64 per share, indicating the trades were regular open-market transactions rather than private transfers.

Does the Argan (AGX) Form 4 show any share purchases by Jeffrey John Ronald Jr.?

No. The Form 4 for July 31, 2026 reports one sale of 5,716 shares of Argan common stock and no purchase transactions. It also lists his post-transaction direct and indirect holdings but does not disclose any acquisitions in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jeffrey John Ronald Jr.

(Last) (First) (Middle)

C/O ARGAN, INC.

4075 WILSON BOULEVARD, SUITE 440

(Street)

ARLINGTON VIRGINIA 22203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2026		S		5,716(1)	D	$579.64	2,533	D
Common Stock								8,000	I	John R. Jeffrey, IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 31, 2026, the Reporting Person sold 5,716 shares of the Issuer's common stock on the open market at an average price of $579.64 per share.

	/s/ John R. Jeffrey, Jr.	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)